The Parallel Artificial Membrane Permeability Assay (PAMPA) is a high-throughput, non-cell-based in vitro method used to measure a compound's passive transcellular permeability. It models diffusion across a gastrointestinal tract or blood-brain barrier by quantifying the rate at which a molecule traverses an artificial lipid membrane infused into a porous filter support.
Glossary
PAMPA

What is PAMPA?
A high-throughput in vitro method for modeling passive transcellular permeability, often integrated with in silico predictive models.
PAMPA data serves as a critical input for training Quantitative Structure-Property Relationship (QSPR) models, enabling rapid in silico screening of oral bioavailability. By providing a standardized, reproducible measurement of passive diffusion decoupled from active transport and metabolism, it directly informs ADMET prediction workflows and guides medicinal chemistry optimization.
Key Features of PAMPA
The Parallel Artificial Membrane Permeability Assay (PAMPA) is a critical high-throughput screening tool for predicting passive transcellular permeability. Understanding its core components is essential for interpreting in silico predictions.
The Artificial Membrane Barrier
PAMPA utilizes a lipid-infused artificial membrane—typically a mixture of phospholipids dissolved in an organic solvent like dodecane—coated onto a porous filter support. This creates a simplified, reproducible model of the intestinal epithelial bilayer. Unlike cell-based assays (e.g., Caco-2), it lacks active transporters and paracellular pores, isolating the passive transcellular diffusion mechanism. The lipid composition can be tuned; for example, a porcine brain lipid extract is used to model the Blood-Brain Barrier (BBB-PAMPA).
The Double-Sink Method
To maintain sink conditions and mimic in vivo absorption, a pH gradient and a scavenger are often employed. The donor compartment is typically buffered at pH 5.5–6.5, while the acceptor compartment is at pH 7.4. A surfactant or serum protein in the acceptor well binds permeated molecules, preventing back-diffusion. This 'double-sink' approach creates a unidirectional flux, ensuring the effective permeability (P_e) measurement reflects true absorption potential rather than an equilibrium state.
Permeability Calculation & Classification
The effective permeability (P_e) is calculated from the rate of compound appearance in the acceptor compartment, typically expressed in cm/s. Results are benchmarked against known standards:
- High Permeability: P_e > 10 × 10⁻⁶ cm/s (e.g., verapamil)
- Low Permeability: P_e < 1 × 10⁻⁶ cm/s (e.g., ranitidine) This binary classification directly informs the Biopharmaceutics Classification System (BCS) and correlates strongly with human oral absorption fraction.
Unstirred Water Layer (UWL) Correction
A critical artifact in PAMPA is the Unstirred Water Layer (UWL), a stagnant aqueous boundary adjacent to the membrane. For highly permeable lipophilic compounds, diffusion across the UWL becomes the rate-limiting step, causing an underestimation of true membrane permeability. Advanced protocols apply a pKa^{flux} correction or use vigorous stirring to minimize UWL thickness. In silico models trained on PAMPA data must account for this, often by incorporating Abraham solvation parameters to deconvolute UWL resistance from membrane resistance.
Correlation with In Silico Models
PAMPA data serves as a gold-standard training endpoint for Quantitative Structure-Property Relationship (QSPR) models. Key molecular descriptors used to predict PAMPA permeability include:
- LogP/LogD: Partition coefficient as a measure of lipophilicity
- Topological Polar Surface Area (TPSA): A proxy for hydrogen bonding capacity
- Molecular Weight: Correlates inversely with diffusion coefficient Graph Neural Networks (GNNs) trained on PAMPA datasets can generalize beyond the Lipinski rule-of-five space, predicting permeability for macrocycles and PROTACs.
PAMPA vs. Caco-2 Assay
While both measure permeability, they provide distinct information:
- PAMPA: Isolates passive transcellular transport. High-throughput, low cost, and highly reproducible.
- Caco-2: A cell-based assay expressing active transporters (e.g., P-gp efflux) and tight junctions. It captures active uptake, efflux, and paracellular transport. A high PAMPA permeability but low Caco-2 permeability strongly suggests the compound is an efflux transporter substrate, a key liability flagged in drug discovery.
PAMPA vs. Cell-Based Permeability Assays
A systematic comparison of the Parallel Artificial Membrane Permeability Assay against common cell-based monolayer techniques for modeling passive and active transcellular transport.
| Feature | PAMPA | Caco-2 | MDCK |
|---|---|---|---|
Membrane Composition | Artificial lipid/oil mixture on filter support | Human colon carcinoma monolayer | Madin-Darby canine kidney monolayer |
Transport Mechanism Modeled | Passive transcellular only | Passive, active uptake, efflux, paracellular | Passive, active uptake, efflux, paracellular |
Expression of Transporters | |||
Expression of P-glycoprotein (P-gp) | |||
Tight Junction Formation | |||
Assay Throughput | Very High (> 1000 cmpds/week) | Medium (100-300 cmpds/week) | High (300-500 cmpds/week) |
Typical Culture Time | None (artificial membrane) | 21 days | 3-7 days |
Cost Per Data Point | $1-5 | $20-50 | $10-30 |
Correlation with Human Oral Absorption | High for passively absorbed drugs | Very High (gold standard) | High |
Suitability for Discovery Screening | Excellent (primary screen) | Limited (secondary screen) | Good (secondary screen) |
Mechanistic Deconvolution | Isolates passive permeability | Requires inhibitor studies | Requires inhibitor studies |
Frequently Asked Questions
Explore the foundational concepts of the Parallel Artificial Membrane Permeability Assay, a critical high-throughput method for predicting passive transcellular permeability in drug discovery.
The Parallel Artificial Membrane Permeability Assay (PAMPA) is a high-throughput, non-cell-based in vitro method used to measure the passive, transcellular permeability of drug candidates. It works by creating an artificial lipid membrane infused with a lipophilic solvent, such as hexadecane or lecithin, on a porous filter support that separates a donor compartment from an acceptor compartment. The test compound is introduced into the donor well, and its concentration in the acceptor well is measured over time, typically via UV spectroscopy or LC-MS. The resulting effective permeability (Pe) is calculated from the flux rate, providing a direct measurement of a molecule's ability to diffuse through a passive lipid bilayer without the confounding influence of active transporters or paracellular routes.
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Related Terms
Explore the key concepts, computational models, and physicochemical properties that intersect with the Parallel Artificial Membrane Permeability Assay.
ADMET Prediction
The computational estimation of a drug candidate's Absorption, Distribution, Metabolism, Excretion, and Toxicity profile. PAMPA specifically addresses the absorption component by modeling passive transcellular permeability, a critical input for predicting oral bioavailability. In silico ADMET models often use PAMPA data as a training endpoint.
LogP
The logarithm of a compound's partition coefficient between octanol and water, serving as a key quantitative measure of molecular lipophilicity. PAMPA permeability is strongly correlated with LogP, as a compound must possess sufficient lipophilicity to partition into the lipid membrane but not so much that it becomes trapped.
Oral Bioavailability
The fraction of an orally administered dose that reaches systemic circulation unchanged. It is a composite parameter influenced by:
- Solubility in gastrointestinal fluids
- Permeability across the intestinal epithelium (modeled by PAMPA)
- First-pass metabolism in the liver and gut wall
Lipinski's Rule of Five
A heuristic set of four physicochemical property guidelines for estimating oral bioavailability. One rule states that the calculated LogP should be less than 5. PAMPA helps validate whether a compound meeting the Rule of Five criteria actually exhibits the expected passive permeability, providing experimental confirmation of the computational filter.
Blood-Brain Barrier Penetration
The prediction of a molecule's ability to cross the highly selective endothelial membrane separating circulating blood from the brain's extracellular fluid. A specialized variant, the BBB-PAMPA, uses a lipid mixture mimicking the blood-brain barrier's unique composition to model CNS penetration potential in a high-throughput format.
Applicability Domain
The theoretical region of chemical space within which a predictive model's estimations are reliable. When training an in silico model on PAMPA data, defining the applicability domain is critical. A model should not be trusted to predict permeability for compounds structurally or physicochemically dissimilar to those in its training set.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us